Supply Chain

Johnson and Johnson's DePuy Synthes Products signed off on an agreement to acquire Medical Enterprises Distribution's assets, including the automated ME1000 Surgical Impactor for use in hip replacement procedures.

President Donald Trump unveiled a proposal May 11 to slash the prices of pharmaceutical drugs, The New York Times reports.

McKesson Medical-Surgical offers a comprehensive portfolio of products and services for ASCs, including custom procedure trays, IV therapy and pharmaceuticals.

The FDA added EpiPen to its drug shortages list, after manufacturing delays disrupted available supply, U.S. News & World Report reports.

Takeda Pharmaceutical investors may have been skeptical of Takeda's $62 billion acquisition of Shire at first, but Bloomberg believes they'll eventually come around.

Pharmaceutical and medical device companies experienced an abnormal spike in problems in the first quarter of 2018, according to Stericycle Expert Solution's U.S. Recall Index.

Valeant CEO Joseph Papa was on CNBC to discuss the company's first quarter 2018 earnings report, which for the first time since 2015 touted organic growth.

Specialty biopharmaceutical company EyePoint Pharmaceuticals reported $928,000 in revenue for the third quarter, up from $590,000 year over year.

Surgical device manufacturing company Encision generated $336,000 in net income for fiscal year 2018, up from a $729,000 loss the previous year.

To further distance itself from its tumultuous past, Valeant Pharmaceuticals is rebranding as Bausch Health Companies, effective in July.